Aurobindo Pharma Q2FY23; 41% Fall in Profits
● Nov 14, 2022
Aurobindo Pharma Ltd.‘s revenue in Q2FY23 fell 3% to ₹ 5,739 crores. Consolidated Profit came at ₹ 409 crores showcasing...
